Key facts
- Notable investors include Enterprise Ireland, Texas Medical Center, RCSI.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Tympulse Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Tympulse Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Tympulse Medical
Developer of an ear drum repair system designed to provide an effective treatment for burst eardrums. The company's technology offers a self-anchoring bioimplant that can be delivered through the ear canal, enabling patients with hearing loss due to eardrum damage to receive a cost-effective treatment without the need for surgery or general anaesthesia.
- Sector
- Healthcare
- HQ
- Dublin, Ireland
- Founded
- 2022
- Employees
- 2
- Website
- tympulsemed.com/
- Ownership
- Privately Held (backing)
Tympulse Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Tympulse Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Tympulse Medical in its N-PORT filings yet. We sweep new filings monthly.